Vol. 17, No. 3
Fall 2007
The Institute for Neurosciences: At the Vanguard of Specialized Care
Nine Winthrop Specialists Named to New York Magazine's “Best Doctors List
Good Health - It's in Our Hands
Tuskegee Airman Regains the Gift of Sight
Stroke Care at Winthrop
Under the Big Top
Golfing for the Kids
Pat Lyons Foundation Shows Unwavering Support for Generation of Survivors Program
Winthrop Opens LI's Only Hypertrophic Cardiomyopathy Center
Migliozzi Family Donates Rocking Chair to NICU
Jay's World Foundation Shows Ongoing Support
Winthrop's Home Health Agency Tops National List Again
Clinical Trials: Bringing the Future of Medicine to Long Island
2007 MineolaStreet Fair
Back to Publications
|
Long Island's first and only comprehensive
Hypertrophic Cardiomyopathy
(HCM) Center has opened at
Winthrop-University Hospital.
The most common cause of heartrelated
sudden death in people under
30, HCM is a well-recognized cause of
heart failure, chest pain, shortness of
breath and premature death in adults.
The condition is characterized by
excessive thickening of the heart
muscle, which makes it difficult for
the heart to pump blood effectively.
This can result in shortness of breath,
lightheadedness, palpitations and
even heart failure. In rare instances,
it can lead to sudden collapse and
even death during or following rigorous
exercise.
Under the expert leadership of
Srihari S. Naidu, MD, Director of
Winthrop's Cardiac Catheterization
Center, and well known as a clinician
and researcher in the field of interventional
cardiology, Winthrop's new
HCM Center offers comprehensive,
expert care for HCM patients.
Treatment options include:
- Screening and Diagnosis
- Genetic Counseling /
Screening
- Electrophysiologic
Testing
- Lifestyle Modification
Counseling
- Medical Therapy
- Permanent Pacemaker
- Alcohol Septal Ablation (ASA)
- Surgical Myectomy
(open-heart surgery)
- Implantable Defibrillator (ICD)
Over the past year, Dr. Naidu has initiated
the use of alcohol septal ablation at
Winthrop. "It is an effective, minimally
invasive treatment technique for qualified
HCM patients in whom medical
therapy has failed," he said. "The procedure
provides a less invasive
alternative to open-heart
surgery and involves the controlled
injection of a small
amount of absolute alcohol
into the heart to destroy
excessive heart muscle in the
septum. We have had great
success with it in appropriate
patients."
Before joining Winthrop,
Dr. Naidu introduced the technique at
New York Presbyterian Hospital Ð
Cornell Medical Center. Dr. Naidu has
also developed modifications to the procedure,
which have been published in
prestigious peer-reviewed medical journals.
Now at Winthrop, Dr. Naidu is
frequently asked to lecture on and
teach the procedure both locally and
nationally, and is a regularly invited
speaker at the American Heart
Association and American College of
Cardiology annual scientific sessions.
A component of Winthrop's Division
of Cardiology and the Hospital's Institute
for Heart Care, the HCM Center has
been named a Center of Excellence
by the national Hypertrophic Cardiomyopathy
Association (HCMA). In
November, Winthrop and the HCMA
will co-sponsor Long Island's first
HCM Symposium, which will be open
to patients, their families and healthcare
providers.
For information about Winthrop's
Hypertrophic Cardiomyopathy Center,
call (516) 663-9696.
|
